All News | Regulatory

CONTROLLED SUBSTANCES NEWS

Nov 25, 2017
DEA Begins Emergency Scheduling of Cyclopropyl Fentanyl
Nov 25, 2017
Final Rule Placing Dronabinol Drug Syndros in Schedule II
Nov 18, 2017
GAO Reports to Senate Requesters on Low Participation in Unused Drug Collection Program
Nov 14, 2017
DEA Adjusts 2017 Aggregate Production Quotas in Response to Concerns
Nov 14, 2017
Another Synthetic Cannabinoid Is Placed in Schedule I
Nov 6, 2017
Florida Residents Plead Guilty to Operating Steroid, Prescription Drug Lab
Oct 31, 2017
Insys Founder, Six Officials Face Charges of Fraud Over Fentanyl-based Cancer Drug
Oct 30, 2017
Controlled Prescription Drugs Less Often Abused but Still Highly Available
Oct 26, 2017
Trump Signs Order on Drug Crisis; Commission Report Expected Next Week
Oct 23, 2017
Two Chinese Nationals Indicted for Manufacture of Illegal Drugs for Distribution to U.S. Customers
Oct 16, 2017
Final Rule Keeps Three Synthetic Cannabinoids in Schedule I
Oct 10, 2017
Pharmacy Manager Pleads Guilty to Wire Fraud, Money Laundering
Oct 9, 2017
Community Pharmacists Ask for Increased Role in Addressing Opioid Crisis
Oct 4, 2017
Robert Patterson Designated New DEA Acting Administrator
Oct 2, 2017
DEA Removes Naldemedine From Control; Drug Used to Treat Opioid Constipation
Sep 19, 2017
State Attorneys General Seek Information From Opioid Manufacturers, Distributors
Sep 14, 2017
Two More Fentanyl Compounds Slated for Emergency Control
Aug 24, 2017
Treatment Options Improving for People With Opioid Use Disorder, SAMHSA Says
Aug 21, 2017
Detroit Doctor Faces Prison for Role in Diversion Ring
Aug 14, 2017
FDA Seeks Comment on 17 Substances Under International Review
Aug 11, 2017
Trump Directs Administration to Respond to Opioid Emergency
Aug 10, 2017
DEA Proposes Adjustments to 2017 Aggregate Production Quotas and List I Annual Needs Assessment
Aug 8, 2017
2018 Proposed Quotas Reflect Attempts to Rein in Opioid Abuse
Aug 1, 2017
Safeway Settles Allegations of Failure to Timely Report Diversion
Jul 31, 2017
Utah Must Provide Prescription Records to DEA in Response to Subpoena

Copyright © Thompson Controlled Subtances, a division of CBIS. All rights reserved.